Literature DB >> 3384768

Septicaemia due to gram-positive cocci in cancer patients.

A Del Favero1, F Menichetti, G Bucaneve, V Minotti, S Pauluzzi.   

Abstract

Episodes of septicaemia caused by Gram-positive bacteria in five separate investigations of empirical antibiotic treatment for fever in patients with neoplastic disease have been analysed according to the antimicrobial agents administered and the outcome. The results suggest that the addition of an 'anti-staphylococcal agent', such as co-trimoxazole, vancomycin or teicoplanin, to the standard two-drug regimen (a beta-lactam antibiotic and an aminoglycoside) may be advantageous in improving the prognosis, particularly in Staphylococcus aureus septicaemia.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3384768     DOI: 10.1093/jac/21.suppl_c.157

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  7 in total

1.  Patterns and outcome of septicemia in neutropenic children with cancer in a Greek hospital.

Authors:  E Roilides; V Sidi; N Gompakis; M Tsivitanidou; A Katsaveli; D Koliouskas
Journal:  Infection       Date:  1998 May-Jun       Impact factor: 3.553

2.  Cost analysis of 2 empiric antibacterial regimens containing glycopeptides for the treatment of febrile neutropenia in patients with acute leukaemia.

Authors:  G Bucaneve; F Menichetti; A Del Favero
Journal:  Pharmacoeconomics       Date:  1999-01       Impact factor: 4.981

3.  Teicoplanin pharmacokinetics in patients undergoing continuous ambulatory peritoneal dialysis after intravenous and intraperitoneal dosing.

Authors:  D R Guay; W M Awni; C E Halstenson; M T Kenny; W F Keane; G R Matzke
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

Review 4.  Teicoplanin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.

Authors:  D M Campoli-Richards; R N Brogden; D Faulds
Journal:  Drugs       Date:  1990-09       Impact factor: 9.546

5.  Ceftriaxone versus aztreonam plus cefazolin for infections in cancer patients with adequate neutrophil counts.

Authors:  F Menichetti; A Del Favero; G Bucaneve; V Minotti; L Patoia; S Pauluzzi
Journal:  Infection       Date:  1990 May-Jun       Impact factor: 3.553

6.  Interventional antimicrobial therapy in febrile neutropenic patients. Study Group of the Paul Ehrlich Society for Chemotherapy.

Authors:  H Link; G Maschmeyer; P Meyer; W Hiddemann; W Stille; M Helmerking; D Adam
Journal:  Ann Hematol       Date:  1994-11       Impact factor: 3.673

7.  Microbial spectrum and drug resistance profile in solid malignancies in a large tertiary hospital from Palestine.

Authors:  Rama Rabayah; Ranyah B Alsayed; Adham Abu Taha; Husam Salameh; Riad Amer; Ali Sabateen; Banan M Aiesh; Sa'ed H Zyoud
Journal:  BMC Infect Dis       Date:  2022-04-18       Impact factor: 3.667

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.